{
    "2019-08-30": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Pharma Stock Roundup: JNJ's Opioid Lawsuit, Regulatory Nod for LLY, BMY, RHHBY Drugs",
                "features": {
                    "keywords": [
                        "JNJ",
                        "Opioid",
                        "Lawsuit",
                        "Regulatory",
                        "Nod",
                        "LLY",
                        "BMY",
                        "RHHBY",
                        "Drugs"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "AbbVie Ends Rova-T Program as 3rd Lung Cancer Study Fails",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Rova-T",
                        "Program",
                        "Lung",
                        "Cancer",
                        "Study",
                        "Fails"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Notable ETF Outflow Detected - IXJ, ABBV, LLY, CVS",
                "features": {
                    "keywords": [
                        "ETF",
                        "Outflow",
                        "IXJ",
                        "ABBV",
                        "LLY",
                        "CVS"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}